Matching of controls may lead to biased estimates of specificity in the evaluation of cancer screening tests

Journal of Clinical Epidemiology

Volumn 66, Issue 2, 2013, Pages 202-208

  Brenner, Hermann ^a   Altenhofen, Lutz ^b   Tao, Sha ^a  

^a GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^b Central Research Institute of Ambulatory Health Care in Germany   (Germany)

Author keywords

Bias; Early detection; Matching; Screening; Specificity; Statistical methods

Indexed keywords

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; CANCER PATIENT; CANCER SCREENING; CLINICAL ASSESSMENT TOOL; COLONOSCOPY; COLORECTAL CANCER; CONTROLLED STUDY; EARLY DIAGNOSIS; FEMALE; GERMANY; HUMAN; IMMUNOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; OCCULT BLOOD; PRIORITY JOURNAL; QUALITY CONTROL PROCEDURES; SEX DIFFERENCE; SPECIFICITY ANALYSIS;

AGE DISTRIBUTION; AGED; AGED, 80 AND OVER; BIAS (EPIDEMIOLOGY); CASE-CONTROL STUDIES; COLONOSCOPY; COLORECTAL NEOPLASMS; DATABASES, FACTUAL; EARLY DETECTION OF CANCER; FEMALE; GERMANY; HUMANS; MALE; MASS SCREENING; MIDDLE AGED; OCCULT BLOOD; PREDICTIVE VALUE OF TESTS; REFERENCE VALUES; RISK FACTORS; SENSITIVITY AND SPECIFICITY; SEX DISTRIBUTION;

EID: 84871325315     PISSN: 08954356     EISSN: 18785921     Source Type: Journal    
DOI: 10.1016/j.jclinepi.2012.09.008     Document Type: Article

References (45)

1. L.J. Bosch, B. Carvalho, R.J. Fijneman, C.R. Jimenez, H.M. Pinedo, and M. van Engeland Molecular tests for colorectal cancer screening Clin Colorectal Cancer 10 2011 8 23
2. X. Luo, B. Burwinkel, S. Tao, and H. Brenner MicroRNA signatures - novel biomarker for colorectal cancer? Cancer Epidemiol Biomark Prev 20 2011 1272 1286
3. S. Tao, S. Hundt, U. Haug, and H. Brenner Sensitivity estimates of blood based tests for colorectal cancer detection: impact of overrepresentation of advanced stage disease Am J Gastroenterol 106 2011 242 253
4. B. Dudouet, L. Jacob, P. Beuzeboc, H. Magdalenat, S. Robine, and Y. Chapuis Presence of villin, a tissue-specific cytoskeletal protein, in sera of patients and an initial clinical evaluation of its value for the diagnosis and follow-up of colorectal cancers Cancer Res 50 1990 438 443
5. T.H. Schiedeck, C. Wellm, U.J. Roblick, R. Broll, and H.P. Bruch Diagnosis and monitoring of colorectal cancer by L6 blood serum polymerase chain reaction is superior to carcinoembryonic antigen-enzyme-linked immunosorbent assay Dis Colon Rectum 46 2003 818 825
6. M.N. Holten-Andersen, I.J. Christensen, H.J. Nielsen, H. Lilja, G. Murphy, and V. Jensen Measurement of the noncomplexed free fraction of tissue inhibitor of metalloproteinases 1 in plasma by immunoassay Clin Chem 48 2002 1305 1313
7. W.K. Leung, K.F. To, E.P. Man, M.W. Chan, A.H. Bai, and A.J. Hui Quantitative detection of promoter hypermethylation in multiple genes in the serum of patients with colorectal cancer Am J Gastroenterol 100 2005 2274 2279
8. J.M. Lutz, S. Francisci, E. Mugno, M. Usel, V. Pompe-Kirn, and J.-W. Coebergh Cancer prevalence in Central Europe: the EUROPREVAL Study Ann Oncol 14 2003 313 322
9. D. Forman, D. Stockton, H. Moller, M. Quinn, P. Babb, and R. De Angelis Cancer prevalence in the UK: results from the EUROPREVAL Study Ann Oncol 14 2003 648 654
10. N. Segnan, C. Senore, B. Andreoni, H. Aste, L. Bonelli, and C. Crosta Baseline findings of the Italian multicenter randomized controlled trial of "once only sigmoidoscopy" - SCORE J Natl Cancer Inst 94 2002 1763 1772
11. W.G. Hocking, P. Hu, M.M. Oken, S.D. Winslow, P.A. Kvale, and P.C. Prorok Lung cancer screening in the randomized Prostate, Lung, Colorectal, and Ovarian (PLCO) Cancer Screening Trial J Natl Cancer Inst 102 2010 722 731
12. P. Maisonneuve, V. Bagnardi, M. Bellomi, L. Spaggiari, G. Pelosi, and C. Rampinelli Lung cancer risk prediction to select smokers for screening CT - a model based on the Italian COSMOS trial Cancer Prev Res 4 2011 1778 1789
13. L.L. Kupper, J.M. Karon, D.G. Kleinbaum, H. Morgenstern, and D.K. Lewis Matching in epidemiologic studies: validity and efficiency considerations Biometrics 37 1981 271 291
14. M.C. Costanza Matching Prev Med 24 1995 425 433
15. T. Stürmer, and H. Brenner Degree of matching and gain in power and efficiency in case-control studies Epidemiology 12 2001 101 108
16. H. Brenner, M. Hoffmeister, C. Stegmaier, G. Brenner, L. Altenhofen, and U. Haug Risk of progression of advanced adenomas to colorectal cancer by age and sex: estimates based on 840,149 screening colonoscopies Gut 56 2007 1585 1589
17. H. Brenner, L. Altenhofen, and M. Hoffmeister Sex, age and birth cohort effects in colorectal neoplasms: a cohort analysis Ann Intern Med 152 2010 697 703
18. S. Hundt, U. Haug, and H. Brenner Comparative evaluation of immunochemical fecal occult blood tests for colorectal adenoma detection Ann Intern Med 150 2009 162 169
19. H. Brenner, S. Tao, and U. Haug Low-dose aspirin use and performance of immunochemical fecal occult blood tests JAMA 304 2010 2513 2520
20. L. Guittet, V. Bouvier, N. Mariotte, J.P. Vallee, D. Arsène, and S. Boutreux Comparison of a guaiac based and an immunochemical faecal occult blood test in screening for colorectal cancer in a general average risk population Gut 56 2007 210 214
21. L.G. van Rossum, A.F. van Rijn, R.J. Laheij, M.G. van Oijen, P. Fockens, and H.H. van Krieken Random comparison of guaiac and immunochemical fecal occult blood tests for colorectal cancer in a screening population Gastroenterology 135 2008 82 90
22. D.I. Park, S. Ryu, Y.H. Kim, S.H. Lee, C.K. Lee, and C.S. Eun Comparison of guaiac-based and quantitative immunochemical fecal occult blood testing in a population at average risk undergoing colorectal cancer screening Am J Gastroenterol 105 2010 2017 2025
23. L. van Dam, E.J. Kuipers, and M.E. van Leerdam Performance improvements of stool-based screening tests Best Pract Clin Gastroenterol 24 2010 479 492
24. M.J. Duffy, L.G. van Rossum, S.T. van Turenhout, O. Malminiemi, C. Sturgeon, and R. Lamerz Use of faecal markers in screening for colorectal neoplasia: a European group on tumor markers position paper Int J Cancer 128 2011 3 11
25. H. Brenner, U. Haug, and S. Hundt Inter-test agreement and quantitative cross-validation of immunochromatographical fecal occult blood tests Int J Cancer 127 2010 1643 1649
26. H. Brenner, U. Haug, and S. Hundt Sex differences in performance of fecal occult blood testing Am J Gastroenterol 105 2010 2457 2464
27. U. Haug, S. Hundt, and H. Brenner Quantitative immunochemical fecal occult blood testing for colorectal adenoma detection: evaluation in the target population of screening and comparison with qualitative tests Am J Gastroenterol 105 2010 682 690
28. http://www.r-biopharm.com/product-site.php?product-range=Clinical Diagnostics&product-class-one=R2FzdHJvZW50ZXJvbG9neQ==&product-class- two=Q29sb24gQ2FuY2VyIFByZXZlbnRpb24=&, last accessed 3 January 2012.
29. A. Shiotani, H. Iishi, N. Uedo, M. Kumamoto, Y. Nakae, and S. Ishiguro Histologic and serum risk markers for noncardia early gastric cancer Int J Cancer 115 2005 463 469
30. C. Mukoubayashi, K. Yanaoka, H. Ohata, K. Arii, H. Tamai, and M. Oka Serum pepsinogen and gastric cancer screening Intern Med 46 2007 261 266
31. S. Tao, U. Haug, K. Kuhn, and H. Brenner Comparison and combination of blood-based inflammatory markers with faecal occult blood tests for non-invasive colorectal cancer screening Br J Cancer 106 2012 1424 1430
32. L.P. Sun, Y.H. Gong, L. Wang, and Y. Yuan Serum pepsinogen levels and their influencing factors: a population-based study in 6990 Chinese from North China World J Gastroenterol 13 2007 6562 6567
33. T. Singh, and A.B. Newman Inflammatory markers in population studies of aging Ageing Res Rev 10 2011 319 329
34. G.J. van Kamp, S. von Mensdorff-Pouilly, P. Kenemans, R. Verstraeten, C.A. Yedema, and T. Wobbes Evaluation of colorectal cancer-associated mucin CA M43 assay in serum Clin Chem 39 1993 1029 1032
35. K. Huber, J.C. Kirchheimer, A. Sedlmayer, C. Bell, D. Ermler, and B.R. Binder Clinical value of determination of urokinase-type plasminogen activator antigen in plasma for detection of colorectal cancer: comparison with circulating tumor-associated antigens CA 19-9 and carcinoembryonic antigen Cancer Res 53 1993 1788 1793
36. I. Hyodo, T. Doi, H. Endo, Y. Hosokawa, Y. Nishikawa, and M. Tanimizu Clinical significance of plasma vascular endothelial growth factor in gastrointestinal cancer Eur J Cancer 34 1998 2041 2045
37. R. Douard, V. Le Maire, P. Wind, J.P. Sales, F. Dumas, and L. Fayemendi Carcinoembryonic gene member 2 mRNA expression as a marker to detect circulating enterocytes in the blood of colorectal cancer patients Surgery 129 2001 587 594
38. R. Douard, S. Moutereau, V. Serru, J.P. Sales, P. Wind, and P.H. Cugnenc Immunobead multiplex RT-PCR detection of carcinoembryonic genes expressing cells in the blood of colorectal cancer patients Clin Chem Lab Med 43 2005 127 132
39. Gesellschaft der epidemiologischen Krebsregister in Deutschland e.V. (GEKID). GEKID-Atlas. http://www.gekid.de/, last accessed 2 January 2012.
40. U.S. Preventive Services Task Force Screening for colorectal cancer: U.S. preventive services task force recommendation statement Ann Intern Med 149 2008 627 637
41. B. Levin, D.A. Lieberman, B. McFarland, K.S. Andrews, D. Brooks, and J. Bond Screening and surveillance for the early detection of colorectal cancer and adenomatous polyps, 2008: a joint guideline from the American Cancer Society, the US Multi-Society Task Force on Colorectal Cancer, and the American College of Radiology Gastroenterology 134 2008 1570 1595
42. W. Schmiegel, A. Reinacher-Schick, D. Arnold, U. Graeven, V. Heinemann, and R. Porschen Update S3 guidelines colorectal cancer 2008 in German Z Gastroenterol 46 2008 799 840
43. A.A. Powell, D.J. Burgess, S.W. Vernon, J.M. Griffin, J.P. Grill, and S. Noorbaloochi Colorectal cancer screening mode preferences among US veterans Prev Med 49 2009 442 448
44. C. Stock, and H. Brenner Utilization of lower gastrointestinal endoscopy and fecal occult blood test in 11 European countries: evidence from the Survey of Health, Aging and Retirement in Europe (SHARE) Endoscopy 42 2010 546 556
45. L.A. Garcia Rodriguez, and S. Hernandez-Diaz Risk of uncomplicated peptic ulcer among users of aspirin and nonaspirin nonsteroidal anti-inflammatory drugs Am J Epidemiol 159 2004 23 31